AC Immune Presents New Phase 1 Data Indicating Higher Uptake of TDP-43 PET Tracer ACI-19626 in Patients with ALS

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/13/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. MSFT
9. CRM
10. CRWV

Go back to AC Immune Presents New Phase 1 Data Indicating Higher Uptake of TDP-43 PET Tracer ACI-19626 in Patients with ALS
(NASDAQ: ACIU) Delayed: 2.31 +0.05 (2.21%)
Previous Close $2.26    52 Week High $19.97 
Open $2.28    52 Week Low $10.36 
Day High $2.36    P/E N/A 
Day Low $2.25    EPS $0.00 
Volume 266,692